India's Senores Pharma rises on upbeat quarterly results, outlook
** Shares of India's Senores Pharmaceuticals SENO.NS rise about 6% to 828.01 rupees ** Drugmaker posted about 84% rise in quarterly profit y/y on Tuesday ** Co's management maintains revenue and PAT guidance of 50% and 100%, respectively, for FY26 ** Trading vols at 969,772 shares, almost 3x the 30-day avg of 348,812 shares ** SENO had risen about 45% in 2025, ~4.5% down so far in 2026 ($1 = 91.6910 Indian rupees) (Reporting by Surbhi Misra in Bengaluru) ((Surbhi.Misra@thomsonreuters.com | X: https://twitter.com/SurbhiMisra_ |;))
Recent news on Senores Pharmaceuticals
See all newsBrief: Senores Pharmaceuticals Approves Re-Appointment Of Swapnil Jatinbhai Shah As Managing Director
Brief: Senores Pharmaceuticals Says U.S.FDA Completes Inspection At Unit's Vadodara Facility
Brief: Senores Pharmaceuticals Says To Incorporate Units In Mexico, Canada
Brief: Senores Pharmaceuticals Ltd June-Quarter Consol Net Profit 307.2 Million Rupees
Brief: Senores Pharmaceuticals March-Quarter Consol Net Profit 316.1 Million Rupees